GlassScriptPhysician profile
Jamie G House
NPI 1205816782
$1,469.14
in general payments reported to CMS, 2019-2025
15 companies · $422 in 2025
The $422 reported for 2025 was more than what 75% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $120 · 2021: $151 · 2022: $167 · 2023: $202 · 2024: $154 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Piramal Critical Care | $374.14 | 2022-2025 | |
| Medtronic, INC. | $362.13 | 2022-2025 | Synchromedii |
| Allergan, INC. | $195.15 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $165.43 | 2019 | |
| Abbvie INC. | $98.16 | 2021-2024 | |
| Dentsply Ih Ab | $86.43 | 2025 | Navina Rectal Catheter Set Regular |
| Medtronic USA, INC. | $37.74 | 2019-2020 | |
| Coloplast Corp | $29.73 | 2022 | |
| Grt US Holding, INC. | $24.21 | 2020 | |
| Smith+Nephew, INC. | $20.15 | 2021 | |
| Lundbeck LLC | $17.08 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $16.78 | 2021 | |
| Amgen INC. | $16.38 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $13.79 | 2023 | Bard Urinary Drainage Bag |
| Saol Therapeutics INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.